Bausch Health Cos Inc (id:13309 BHC)
10.85 CAD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 12/25/2024 8:19:51 AM)
Exchange closed, opens in 1 hour 10 minutes
About Bausch Health Cos Inc
Market Capitalization 4.41B
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
Headquarters (address) |
2150 St. ElzEar Boulevard West Laval H7L 4A8 QC Canada |
Phone | 514 744 6792 |
Website | https://www.bauschhealth.com |
Employees | 20K |
Sector | Healthcare |
Industry | Drug Manufacturers Specialty & Generic |
Ticker | BHC |
Exchange | Toronto Stock Exchange |
Currency | CAD |
52 week range | 5.45 - 15.43 |
Market Capitalization | 4.41B |
Dividend yield forward | 3.59 % |
Dividend yield forward Canada (ID:82, base:381) | 6.14 % |
P/E trailing | -6.67 |
P/E forward | 1.99 |
Price/Sale | 3.00 |
Price/Book | -11.60 |
Beta | 3.00 |
EPS | 3.00 |
EPS Canada (ID:82, base:720) | 2.18 |
Forward Annual Dividend Yield
Forward Annual Dividend Yield: Bausch Health Cos Inc has raised their dividend 3.59 years in a row. This is below the 42132.517500 year average in the 'Drug Manufacturers Specialty & Generic' industry
Forward Annual Dividend Yield
Forward Annual Dividend Yield: Bausch Health Cos Inc has raised their dividend 3.59 years in a row. This is below the 42132.517500 year average in the 'Drug Manufacturers Specialty & Generic' industry